Salarius Pharmaceuticals, Inc. (SLRX)
USD 1.22
(-8.27%)
USD 1.22
(-8.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.84 Million | 5.23 Million | 3.46 Million | 838 Thousand |
| Cost of Revenue | 10.05 Thousand | 6677.00 | 19.18 Thousand | 6913.85 | 4018.95 | 431 Thousand |
| Gross Profit | -10.05 Thousand | -6677.00 | 1.82 Million | 5.22 Million | 3.46 Million | 407 Thousand |
| Operating Expenses | 12.89 Thousand | 22.97 Million | 14.65 Million | 12.84 Million | 11.73 Million | 22.48 Million |
| Selling, General and Administrative Expenses | 5721.20 | 7.13 Million | 6.1 Million | 6.1 Million | 7.71 Million | 10.57 Million |
| Research and Development Expenses | 7173.75 | 15.83 Million | 8.54 Million | 6.91 Million | 4.01 Million | 11.9 Million |
| Other Expenses | - | 8.86 Million | -4.00 | -178.58 Thousand | - | - |
| Cost and Expenses | 12.89 Thousand | 22.97 Million | 14.65 Million | 12.84 Million | 11.73 Million | 22.91 Million |
| Operating Income | -12.89 Thousand | -31.84 Million | -12.81 Million | -7.78 Million | -9.57 Million | -22.07 Million |
| Interest Expense | - | - | - | 3047.00 | - | - |
| Income Tax Expense | - | -233.18 Thousand | -63.87 Thousand | -255.5 Thousand | -1.32 Million | 152 Thousand |
| Earnings before Tax | -12.54 Thousand | -31.6 Million | -12.76 Million | -7.35 Million | -6.93 Million | -21.92 Million |
| Net Income | -12.54 Thousand | -31.37 Million | -12.7 Million | -7.09 Million | -5.6 Million | -21.92 Million |
| Earnings Per Share Basic | -0.00 | -14.77 | -7.68 | -11.39 | -42.90 | -760.47 |
| Earnings Per Share Diluted | -0.00 | -14.77 | -7.68 | -11.39 | -42.90 | -760.47 |
| Weighted Average Shares Outstanding | 3.26 Million | 2.12 Million | 1.65 Million | 623.14 Thousand | 130.74 Thousand | 28.82 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.26 Million | 2.12 Million | 1.65 Million | 623.14 Thousand | 130.74 Thousand | 28.82 Thousand |
| Gross Margin | - | - | 0.99 | 1.00 | 1.00 | 0.49 |
| EBIT Margin | - | - | -6.99 | -1.50 | -2.73 | -26.34 |
| Profit Margin | - | - | -6.90 | -1.36 | -1.62 | -26.16 |
| EBITDA | -12.88 Thousand | -31.6 Million | -12.74 Million | -7.33 Million | -6.92 Million | -22.07 Million |
| Earnings Before Tax Margin | - | - | -6.96 | -1.49 | -2.76 | -26.34 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 17.89 Thousand | - | - | - |
| Cost of Revenue | 1106.00 | 1107.00 | 1105.00 | 10.05 Thousand | 5608.00 | 1669.00 |
| Gross Profit | -1106.00 | -1107.00 | 16.78 Thousand | -10.05 Thousand | -5608.00 | -1669.00 |
| Operating Expenses | 1.46 Million | 1.77 Million | 969.59 Thousand | 12.88 Million | 2.53 Million | 3.97 Million |
| Selling, General and Administrative Expenses | 1.25 Million | 1.52 Million | 909.64 Thousand | - | 1.49 Million | 1.61 Million |
| Research and Development Expenses | 214.44 Thousand | 243 Thousand | 59.95 Thousand | - | 1.03 Million | 2.35 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.46 Million | 1.77 Million | 970.7 Thousand | 12.89 Million | 2.53 Million | 3.97 Million |
| Operating Income | -1.46 Million | -1.77 Million | -970.7 Thousand | -12.89 Million | -2.44 Million | -3.97 Million |
| Interest Expense | - | - | 79.89 Thousand | - | - | - |
| Income Tax Expense | 4.00 | 3.00 | -5.00 | -1.00 | -89.36 Thousand | -120.41 Thousand |
| Earnings before Tax | -1.42 Million | -1.71 Million | -881.79 Thousand | -12.54 Million | -2.44 Million | -3.87 Million |
| Net Income | -1.42 Million | -1.71 Million | -881.79 Thousand | -12.54 Million | -2.44 Million | -3.87 Million |
| Earnings Per Share Basic | -2.37 | -3.27 | -0.22 | - | -0.65 | -1.43 |
| Earnings Per Share Diluted | -2.37 | -3.27 | -0.22 | - | -0.65 | -1.43 |
| Weighted Average Shares Outstanding | 600.41 Thousand | 524.32 Thousand | 3.93 Million | 408.07 Thousand | 3.75 Million | 2.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 600.41 Thousand | 524.32 Thousand | 3.93 Million | 408.07 Thousand | 3.75 Million | 2.7 Million |
| Gross Margin | - | - | 0.94 | - | - | - |
| EBIT Margin | - | - | -54.19 | - | - | - |
| Profit Margin | - | - | -49.28 | - | - | - |
| EBITDA | -1.46 Million | -1.77 Million | -969.6 Thousand | - | -2.52 Million | -3.96 Million |
| Earnings Before Tax Margin | - | - | -54.25 | - | - | - |
5484
EQLB
TQLB
ARD
8033
CLOQ